July 2003: Case Study 1

Published Online: Tuesday, July 1, 2003

KC?s grandmother enters the pharmacy excitedly. She approaches the counter and asks to speak with KC, the pharmacist. She tells KC that she heard from the "girls at my bridge game" that a new product is available for the treatment of overactive bladder. The "girls" told her that it was in the form of a patch. She wants to know whether she should ask her physician to write a prescription for her.

KC knows that her grandmother is frustrated by her overactive bladder problems. She is also embarrassed by her need to wear protective undergarments. The only medication covered by her grandmother?s insurance plan is generic oxy-butynin. Unfortunately, her doctor has determined that oxybu-tynin is not an appropriate therapy for her due to her uncontrolled narrow-angle glaucoma. Due to her limited income, she is unable to afford any medications that are not covered by her insurance plan.

If her grandmother?s insurance plan covers this new patch, is this an appropriate alternative for her?

Click Here For The Answer -----------> [-]

Unfortunately, the new patch contains oxybutynin. Although this patch will provide the ease of twice-weekly patch changes and reduced side effects, it should not be used in patients with urinary retention, gastric retention, or uncontrolled narrow-angle glaucoma.



Latest Articles
Propranolol is red, digoxin is blue. Your pharmacist’s heart may skip a beat if they get a valentine from you.
Health-system pharmacists can play a critical role in managing drug shortages to prevent medical errors and adverse events.
The White House is asking Congress for more than $1.8 billion in emergency funding to combat the Zika virus, which is creeping into the United States and ravaging some foreign countries.
Vertex Pharmaceuticals has received a complete response letter from the FDA for its supplemental new drug application for ivacaftor.
Latest Issues
$auto_registration$
VSEO N/A